METHODOLOGY OF COST-UTILITY ANALYSIS IN PHARMACOECONOMICSTUDIES
pharmacoeconomic cost-utility analysis – CUA is at third place by popularity (10% of studies) among studies of pharmacoeconomic analysis. Main stages of these trials are as follows: cost analysis, utility analysis and results assessment. Each of these stages may have impact on theend data reliabilit...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2015-03-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/27 |
| _version_ | 1797878945212792832 |
|---|---|
| author | R. I. Yagudina I. V. Sorokovikov |
| author_facet | R. I. Yagudina I. V. Sorokovikov |
| author_sort | R. I. Yagudina |
| collection | DOAJ |
| description | pharmacoeconomic cost-utility analysis – CUA is at third place by popularity (10% of studies) among studies of pharmacoeconomic analysis. Main stages of these trials are as follows: cost analysis, utility analysis and results assessment. Each of these stages may have impact on theend data reliability. The results of analysisis CUR coefficient (ICUR), reflecting cost value on utility unit. Correct assessment of analysis results may increase effectiveness of health care budget allocationand reveal more effective and appropriate treatment alternatives. All stages of cost-utility analysis and decision making algorithm are presented in the article. |
| first_indexed | 2024-04-10T02:41:19Z |
| format | Article |
| id | doaj.art-799146cc2e0e49b79cda6f3d649e74ee |
| institution | Directory Open Access Journal |
| issn | 2070-4909 2070-4933 |
| language | Russian |
| last_indexed | 2024-04-10T02:41:19Z |
| publishDate | 2015-03-01 |
| publisher | IRBIS LLC |
| record_format | Article |
| series | Фармакоэкономика |
| spelling | doaj.art-799146cc2e0e49b79cda6f3d649e74ee2023-03-13T07:48:14ZrusIRBIS LLCФармакоэкономика2070-49092070-49332015-03-015291221METHODOLOGY OF COST-UTILITY ANALYSIS IN PHARMACOECONOMICSTUDIESR. I. Yagudina0I. V. Sorokovikov1First Moscow State Medical University named after I.M. Sechenov (Moscow)First Moscow State Medical University named after I.M. Sechenov (Moscow)pharmacoeconomic cost-utility analysis – CUA is at third place by popularity (10% of studies) among studies of pharmacoeconomic analysis. Main stages of these trials are as follows: cost analysis, utility analysis and results assessment. Each of these stages may have impact on theend data reliability. The results of analysisis CUR coefficient (ICUR), reflecting cost value on utility unit. Correct assessment of analysis results may increase effectiveness of health care budget allocationand reveal more effective and appropriate treatment alternatives. All stages of cost-utility analysis and decision making algorithm are presented in the article.https://www.pharmacoeconomics.ru/jour/article/view/27pharmacoeconomicscost-utility analysisthreshold limit value of availability to pay |
| spellingShingle | R. I. Yagudina I. V. Sorokovikov METHODOLOGY OF COST-UTILITY ANALYSIS IN PHARMACOECONOMICSTUDIES Фармакоэкономика pharmacoeconomics cost-utility analysis threshold limit value of availability to pay |
| title | METHODOLOGY OF COST-UTILITY ANALYSIS IN PHARMACOECONOMICSTUDIES |
| title_full | METHODOLOGY OF COST-UTILITY ANALYSIS IN PHARMACOECONOMICSTUDIES |
| title_fullStr | METHODOLOGY OF COST-UTILITY ANALYSIS IN PHARMACOECONOMICSTUDIES |
| title_full_unstemmed | METHODOLOGY OF COST-UTILITY ANALYSIS IN PHARMACOECONOMICSTUDIES |
| title_short | METHODOLOGY OF COST-UTILITY ANALYSIS IN PHARMACOECONOMICSTUDIES |
| title_sort | methodology of cost utility analysis in pharmacoeconomicstudies |
| topic | pharmacoeconomics cost-utility analysis threshold limit value of availability to pay |
| url | https://www.pharmacoeconomics.ru/jour/article/view/27 |
| work_keys_str_mv | AT riyagudina methodologyofcostutilityanalysisinpharmacoeconomicstudies AT ivsorokovikov methodologyofcostutilityanalysisinpharmacoeconomicstudies |